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Objective. Gastric erosion is widespread side effect of nonsteroidal anti-inflammatory drugs. 
To examine the complexity of the brain-gut axis regulation, indomethacin-induced gastric erosion 
formation was studied in connection with somatic and behavioral changes.
Methods. During a constant telemetric recording of heart rate, body temperature, and locomo-
tion of male rats we examined the effects of 24 h fasting, indomethacin (35 mg/kg s.c.) injection, 
and refeeding at 4 h. Behavior was analyzed on elevated plus maze (EPM) at 24 h and somatic 
changes at 72 h.
Results. Gastric erosion developed 4 h after indomethacin injection, healed 72 h later contrasted 
by large injury in the small intestine. As classical signs of chronic stress, body and thymus weight 
were reduced while adrenal weight was enhanced 72 h after indomethacin injection. Fasting by 
itself changed all telemetrically recorded parameters with most prominent decrease in heart rate. 
Indomethacin induced similar diminishing effects with earliest and strongest temperature decrease. 
As a sign of more anxious phenotype locomotion reducing effect of indomethacin injection was 
detected on EPM. The EPM-induced temperature elevation was missing in indomethacin-treated 
animals.
Conclusions. Fasting by itself induce somatic changes, which can make the animals more vulner-
able to ulcerogenic stimuli. Development of indomethacin-induced gastrointestinal lesions happened 
in parallel with disturbances of heart rate, core body temperature, and chronic stress-like somatic 
changes as well as anxiety-like behavior. We have to be more aware of the existence of the brain-gut 
axis and should study changes in the whole body rather than focusing on a specific organ.
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In our aging society the prevalence of locomotor 
disorders are increasing. An account of their analge-
sic and anti-inflammatory effects nonsteroidal anti-
inflammatory drugs (NSAIDs) would be one of the 
best choices for their treatment (Laine 2002). The main 
factor limiting use of NSAIDs is concern about their 
gastrointestinal (GI) side effects (Hawkey 2000; Wallace 
and Vong 2008). Their use is associated with a significant 
risk of GI bleeding, ulcer perforation, and symptomatic 
peptic ulcer disease. Approximately 1-2% of NSAID us-
ers develop upper GI complications per year, a rate 3-5 
times higher than in non-NSAID users (Targownik et 
al. 2008). Experimental studies with NSAIDs confirm 
the clinical data that NSAIDs cause damage to the up-
164 THE COMPLExITY OF NSAID-INDUCED EROSION FORMATION IN RATS
per GI tract and also affect the lower GI tract (Sostres 
et al. 2013).
Indomethacin (IM) which is the most widely studied 
of the NSAID medications was introduced in 1963 for 
the treatment of rheumatoid arthritis and related dis-
eases. A reduction in the biosynthesis of prostaglandin 
through inhibition of cyclooxygenase is the pharmaco-
logical background to both the anti-inflammatory action 
(Vane 1971) and the harmful side effects of IM as well 
as other NSAIDs (Hawkey 2000). IM is widely used 
ulcerogenic stimulus in experimental studies (Filaretova 
2013; Filaretova et al. 2013).
Effects of ulcerogenic stimuli on the GI tract, includ-
ing stress and IM, depend on the general conditions 
of the body as well as on the situation in which the 
person or animal is. Firstly, in critically ill patients the 
health risk of gastric ulceration is about 100% (Laine et 
al. 2008). Secondly, gastroprotective effect of precon-
ditioning stress (Filaretova et al. 2008) confirms that 
gastric ulceration depends on the situation in which 
animal is. Moreover, it is also widely known, that per-
sonality (Magni et al. 1988; Juby and Davis 1991) and 
psychological factors (Magni et al. 1986) like high level 
of anxiety strongly influence the vulnerability, i.e. the 
occurrence and severity of gastric ulcerations (Over-
mier and Murison 2000). In the last few years more 
emphasize was given to the existence of the brain-gut 
axis, thus it became clear that the process goes both 
directions, i.e. the stage of the GI tract strongly influ-
ences our higher brain functions. This aspect has been 
investigated to a lesser degree. This explains why our 
interest was focused on the general changes in the body 
during IM-induced gastric ulceration. Many authors 
deal with the effect of intestinal microbiome on the 
general well-being (e.g. Foster and McVey Neufeld 
2013; Farmer et al. 2014; Tillisch 2014), which can be 
transmitted through neural (nervus vagus) (Klarer et 
al. 2014), hormonal, immune, and metabolic pathways 
(Borre et al. 2014). It was already confirmed that IM 
treatment induce remarkable changes in microbiome 
(Imaeda et al. 2012; Teran-Ventura et al. 2014) and 
vagal nerve function interacts with its effect (Karadi et 
al. 2001). Thus, we might assume that beside somatic 
changes, IM-induced ulceration will be accompanied 
by enhanced anxiety-like symptoms.
In animal models reproducible gastric ulceration 
is induced in fasted animals. Gastric mucosa of fasted 
animal is more susceptible to ulcerogenic stimuli for 
several, local reasons, including an absence of protective 
role of chimus and deficiency of glycoproteins in mucus 
(Dekanski et al. 1975). On the other hand, fasting may 
induce general changes in the body, which makes it more 
vulnerable to ulcerogenic stimuli. This later hypothesis 
requires experimental evidence.
Here we aimed to examine the complex regulation 
of the brain-gut axis after IM treatment. Therefore IM-
induced gastric erosion formation was studied in con-
nection with somatic and behavioral changes.
Materials and Methods
Animals. Subjects were 2-3 month old male rats 
(Wistar for Exp. 1; Charles River Laboratories, Hun-
gary and Sprague Dawley for Exp. 2; Russia) weighting 
250-300 g at the start of the experiments. Food and 
water were available ad libitum, while temperature 
and relative humidity were kept at 21 ± 2°C and 60 ± 
10%, respectively. Rats were kept under 12 h cycle with 
lights on at 22:00 h (Exp. 1) or at 7:00 h (Exp. 2). For 
better evaluation of behavior the animals were kept in 
reversed cycle in Exp.1. Acclimatization to the reversed 
cycle lasted for 2 weeks. It raises the question if there 
is a difference between the effect of IM injection at the 
beginning of the light (more general) or dark phase. 
This question was tested during Exp. 2. As biotelemetry 
required individual housing initially group housed rats 
were single housed after surgery (Exp. 1) or 5 days prior 
to the start of the experiment (Exp. 2). Animals were 
naive to experimentation. Experiments were carried 
out in accordance with the European Communities 
Council Directive recommendations for the care and 
use of laboratory animals (2010/63/EU).
Experiment 1.
Telemetric recording. We implanted VitalView bio-
telemetry emitters (Minimitter Co. Bend, OR, USA) into 
the rats. The emitter was placed into the abdominal cavity 
through a midline abdominal incision under ketamin-
xylazine-pipolphen anesthesia (50-10-5 mg/kg in a volume 
of 2 ml/kg intraperitoneal, i.p.). The negative and positive 
heart rate leads were attached to the anterior right side 
of the chest (near the clavicle) and to the posterior chest 
wall (left to the sternum and anterior to the last rib), re-
spectively. Biotelemetric recordings were made by means 
of a 12-channel VitalView system (Minimitter Co.). Data 
was taken once every minute around the clock and later 
summarized as an average (heart rate and temperature) or 
sum (locomotion) of 1 h or 10 min. Circadian changes were 
calculated by subtracting the average of the values during 
light phase from the dark phase (Filaretova et al. 2011).
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Induction of gastric erosion. After 5 days recovery 
the animals were fasted for 24 h in an empty cage then 
IM was injected subcutaneously (s.c.) at ulcerogenic 
dose (35 mg/kg) at the beginning of the dark phase. 
Four hours after the IM or vehicle (saline with few 
drops of Tween 80) administration some animals (n=8) 
were examined for the development of gastric erosion 
in our experimental conditions (the stress of operation 
is a preconditioning stimulus, which can profoundly 
influence the development of gastric erosion (Filaretova 
et al. 2008)). The majority of the animals (n=14 Control 
and n=14 IM-treated) were refed 4 h after the injection 
and the experiment was continued for another 3 days. 
Recording started 2 days before fasting and lasted 24 h 
after IM injection. During all these periods the heart 
rate, core body temperature, and locomotion were re-
corded automatically.
Elevated plus maze. Twenty-four hours after IM 
administration, the animals were tested on an elevated 
plus maze (EPM) during the beginning of the dark phase 
under red light illumination. Each rat was brought in 
its home cage to the test room and immediately placed 
on the central arena of the EPM with the head facing 
a closed arm. EPM was made from wood, painted dark 
grey and elevated 80 cm above the floor (arm length, 
50 cm; arm width, 20 cm; central platform, 20 x 20 cm; 
closed arm walls height, 30 cm). Surface of maze was 
washed with water and dried prior next animal was 
tested. Test duration was 5 min. Animal’s behavior was 
recorded by camera fixed above the maze and analyzed 
by trained observer later on. Percentage of time spent 
in open arms and open/total (total:open plus closed) 
arm entries ratio (entry:three paws of animal in an arm) 
were calculated and used as measures of anxiety. Closed 
arm entries were considered as indicators of general 
locomotor activity. Next to basic parameters grooming 
(self-grooming with forepaws and scratching with hind 
legs) was also calculated (Mikics et al. 2005).
Experiment 2.
After 5 days of single housing the animals were 
treated as mentioned above (see Induction of gastric 
erosion) at the beginning of the light or dark phase of 
the day. After refeeding at 4 h the animals were moni-
tored for 3 days. The body weight of the animals was 
monitored daily. At the termination of the experiment 
the gastric and the intestinal mucosa were examined 
and the intestinal length was measured. The area (in 
mm2) of the gastric and the small intestinal lesions was 
measured using computer program Image J, summed 
per animal, and used as a lesion score. Adrenal gland and 
thymus weights as well as plasma corticosterone level 
were also examined. Plasma corticosterone measure-
ment was done by a spectrofluorimetric micromethod. 
For details see Filaretova et al. (1998). Intra- and inter-
assay variations of measurements were 5.1% and 7.4%, 
respectively.
Statistical analysis. Data are expressed as mean ± 
SEM. Statistical significance was tested by repeated 
measure ANOVA (for telemetric data and body weight; 
factors treatment and time) or one (EPM; factor treat-
ment) or two ways (morning-evening; factors treatment 
and day) ANOVA module of the StatSoft 11.0 (StatSoft, 
Inc., Tulsa, OK, USA) followed by Newman Keul´s post 
hoc comparisons in the case of significant interactions. 
p<0.05 was considered to be significant.
Results
Experiment 1.
Telemetric recordings. In this experiment we con-
firmed the development of gastric erosion 4 h after the 
IM treatment (erosion area: 19.84 ± 6.4 mm2). At the ter-
mination of the experiment (in 3 days after IM injection) 
significantly smaller erosion (8.8 ± 1.8 mm2) was still visible 
in the stomach with a concomitant severe intestinal damage 
(lesion area in the intestine: 444.6 ± 181.9 mm2).
Twenty-four h fasting by itself induced remark-
able changes in the telemetrically measured parameters 
(Fig. 1). Compared with the previous 24 h (Control, 
normally fed) of the same animals fasting induced 
a significant reduction in the heart rate (treatment: 
F(1,70)=15.6, p<0.01; Fig. 1A). This effect started al-
ready during the third hour of fasting and became more 
pronounced with time (treatment x time interaction: 
F(23,1610)=5.07, p<0.01) despite the lower heart rate of 
the animals during the light phase of the circadian cycle 
(time: F(23,1610)=195.4, p<0.01).
The body temperature changes were not that un-
ambiguous. There was no overall effect of fasting on 
this parameter, but the decrease during the light phase 
(time: F(23,1610)=199.8, p<0.01; Fig. 1B) was more 
explicit in fasting rats (treatment x time interaction: 
F(23,1610)=10.9, p<0.01). It seems that the circadian 
changes was more pronounced in fasted animals (-1.07 
± 0.04°C compared to -0.70 ± 0.04°C; F(1,70)=29.0, 
p<0.01).
Locomotion of fasted animals were higher com-
pared to normally fed rats (treatment: F(1,70)=5.5, 
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p<0.05; Fig. 1C). This parameter also showed circadian 
variation with lower levels during the light phase (time: 
F(23,1610)=108.9, p<0.01), which was influenced by 
fasting at certain time points only (treatment x time 
interaction: F(23,1610)=7.9, p<0.01).
During the first 24 h after IM injection (during gas-
tric ulceration and healing), significant changes were 
detectable in heart rate, core body temperature, and 
locomotion (Fig. 2). Both s.c. IM injection and refeed-
ing induced significant and long-lasting (80-90 min) 
elevations in all three parameters.
In the case of heart rate, there was no overall treat-
ment effect (Fig. 2A). More specifically, the differences 
between vehicle and IM-treated animals were not ap-
parent during the development of gastric ulcer (first 4 h) 
and started just approximately 3 h after refeeding. 
Moreover, the heart rate reducing effect of IM remained 
visible during the light phase with lower overall heart 
rate (time: F(143,2145)=15.7, p<0.01; treatment x time 
interaction: F(143,2145)=2.3, p<0.01).
A slightly different pattern was recognized in the 
case of core body temperature (Fig. 2B). Here there 
was a general treatment effect (F(1,17)=5.18, p<0.05) 
with lower levels in IM-treated rats. This effect started 
already approximately 100 min after IM injection 
and intensified with time with huge difference even 
during the light phase with overall lower levels (time: 
F(143,2431)=32.3, p<0.01; treatment x time interaction: 
F(143,2431)=3.5, p<0.01).
Locomotion showed only circadian changes (time: 
F(23,598)=8.53, p<0.01; Fig. 2C) without any effect of 
IM treatment.
Elevated plus maze. When we tested the anxiety-like 
behavior on the EPM the only significant difference was 
the reduced locomotion (measured by the frequency 
of closed arm entries) of IM-treated animals 24 h after 
ulcerogenic injection (F(1,26)=7.56, p=0.01; Fig. 3C). 
Despite slightly higher open arm time (Fig.3A) and 
the locomotion independent anxiety measure open/
total arm entries (Fig. 3B) only time spend with groom-
ing showed a tendency to be higher in IM-treated rats 
(F(1,13)=3.59, p=0.08; Fig. 3D).
The heart rate of IM-treated animals were lower 24 h 
after the injection (treatment: F(1,17)=12.7, p<0.01; 
Fig. 3E). Although EPM induced a significant elevation 
(time: F(12,2047)=9.5, p<0.01), but this change was 
similar in vehicle vs. IM-treated groups (no interaction 
between treatment and time).
In the case of temperature, not only the IM effect 
was significant (F(1,18)=18.2, p<0.01), but the EPM-
induced elevation (F(12,216)=8.3, p<0.01) was visible in 
vehicle-treated animals only (treatment x time interac-
tion: F(12,216)=3.2, p<0.01; Fig. 3F).
In agreement with the reduced closed arm fre-
quency, the IM-treated animals moved less (treatment: 
F(1,17)=12.7, p<0.01; Fig. 3G). The EPM-induced loco-
motion elevation (time: F(12,204)=9.5; p<0.01) was the 
same in vehicle- and IM-treated animals (no treatment 
x time interaction).
Experiment 2. Twenty-four h fasting reduced the body 
weight of the animals significantly (Fig. 4A, day 0 and 
day 1), which was normalized in vehicle-treated animals 
within 3 days (time: F(2,30)=220.9, p<0.01). IM treatment 
significantly reduced the body weight during the 3 days 
examination period (F(1,15)=17.8, p<0.01). This effect 
was visible only at day 3 as all other measurement was 
practically before the injection (treatment x time interac-
 
Fig. 1. Somatic changes induced by 24 h fasting. (A) Heart 
rate, (B) core body temperature and (C) locomotion were 
monitored by telemetric recordings. n=36; *p<0.05, **p<0.01 
vs. Control, normally fed (samples were taken from the same 
animals 24 h apart); +p<0.05, ++p<0.01 vs. 10:00 h.
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tion: F(2,30)=290.7, p<0.01). The effect of the day (e.g. 
morning or evening injection) had no influence at all, 
even any of its interactions were not significant.
The weight of the thymus was reduced (F(1,15)=126.5, 
p<0.01; Fig. 4B), while the weight of the adrenal gland 
was enhanced (F(1,15)=42.9, p<0.01; Fig. 4C) by IM 
treatment, without any influence of the day (e.g. morn-
ing-evening). In accordance what is widely known in 
rodents, the corticosterone levels were higher during the 
evening than during the morning hours (Fig.4D). The 
IM injection induced opposite changes at the different 
time points (treatment x time interaction: F(1,15)=11.2, 
p<0.01). Namely, injected and sampled during the 
morning hours the resting corticosterone levels were 
elevated 3 days after the IM-treatment, while in case 
the injection/sampling was done during the dark phase 
IM-treatment tended to reduce the levels.
Three days after IM injection, gastric erosion was 
still visible in the stomach of IM-treated, but not vehicle 
treated rats (treatment: F(1,15)=7.3, p=0.01; Fig.4E). 
At the same time intestinal lesions were much more 
pronounced (treatment: F(1,15)=171.6, p<0.01; Fig.4F) 
reflected by reduced length of the intestine as well 
(treatment: F(1,15)=28.4, p<0.01; Fig.4G). Although 
gastric erosion and intestinal length were not influenced 
by the day at all, but the area of intestinal lesions was 
significantly smaller in case the injection/sampling was 
done during the dark phase (day: F(1,15)=6.06, p<0.05; 
treatment x day interaction: F(1,15)=6.06, p<0.05).
Discussion
According to the results obtained, fasting itself in-
duced somatic changes. In both experiments (Exp. 1 
and 2), we confirmed that IM (35 mg/kg s.c.) injected 
to preliminary fasted rats produced hemorrhagic gastric 
mucosal erosion that was visible 4 h after the injection 
and that significantly healed in 3 days. The healing of 
IM-induced gastric erosion was followed by severe 
injury to the small intestine. Parallel to development of 
IM-caused GI lesions significant changes of heart rate, 
core body temperature and chronic stress-like somatic 
changes as well as anxiety-like behavior became ap-
parent. These results suggest that IM-induced gastric 
injury may occur in tandem with complex somatic and 
behavioral changes.
Treatment with IM and other nonselective NSAIDs 
is associated with a high prevalence of GI adverse effects 
(Bjarnason et al. 2007; Hunt and Yuan 2011). Beside 
most widely known adverse side effect in upper GI tract 
NSAIDs may also induced serious adverse effects in the 
small intestine as well as in cardiovascular system (Ng 
and Chan 2010). However, these side effects are inves-
tigated separately. Even the pathogenic mechanisms of 
NSAID-induced injury to the upper GI tract and the 
lower GI tract are still studied separately using differ-
ent experimental models (Laine et al. 2008; Brzozowski 
2010; Wallace 2011). To produce injury to the stomach, 
IM is usually injected to fasting rats or mice (Kato et al. 
2009; Rios et al. 2010; Zelena and Filaretova 2010). On 
the contrary, for induction of injury to the small intestine 
IM is injected to fed animals (Kamei et al. 2008; Yoda et 
al. 2010; Kawahara et al. 2011). The results of the present 
and our previous (Filaretova et al. 2011) studies demon-
Fig. 2. Indomethacin-induced somatic changes. (A) Heart 
rate, (B) core body temperature and (C) locomotion were 
monitored by telemetric method during development and 
healing of gastric erosion induced by single indomethacin 
(35 mg/kg, s.c.) injection in fasted rats. Indomethacin treat-
ment was followed by refeeding 4 h later. n=14; *p<0.05 main 
treatment effect.
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strate that a single IM injection to fasting rats at gastric 
ulcerogenic dose may sequentially induce damage to the 
stomach and then, after refeeding, to the small intestine as 
well. It means that the enough fast healing of IM-induced 
gastric erosion (Filaretova et al. 2001; Filaretova et al. 
2011) is not the end of pathological consequences of IM 
action. These findings suggest that new knowledge about 
mechanisms underlying NSAID-induced GI injury may 
come through integrative approach.
To continue our strategy of using integrative ap-
proach ( Filaretova et al. 2002; Filaretova et al. 2006; 
Filaretova et al. 2009; Filaretova 2011; Filaretova et al. 
2014) and to understand what happens with the body 
as a whole (“in vivo”), in the present study we evaluated 
somatic and behavior changes in rats treated with IM at 
gastric ulcerogenic dose. Additionally to an appearance 
of severe injury to the small intestine, body and thymus 
weights were reduced while adrenal weight and the 
morning plasma corticosterone levels were enhanced 
3 days after IM injection (Fig. 4). The long lasting increase 
in corticosterone levels together with the enlargement of 
the adrenal gland and the thymus involution confirmed 
a chronic activation of hypothalamic-pituitary-adren-
ocortical axis which could be a sign of inflammation. 
Indeed, besides injury to the small intestine as well as 
decrease in the intestinal length, a sign of hypermotility 
as a pathogenic element of inflammation (Filaretova et 
al. 2002), was detected in this part of GI tract (Teran-
Ventura et al. 2014). It is worthy of note that the similar 
results on long lasting effects of IM were reproduced in 
both experiments. Moreover, to study circadian varia-
tion, in Exp. 2 we examined the effects of IM injected in 
the morning and in the evening hours and reproduced 
the most results independently on the injection time 
with two exceptions related to the effect on plasma 
corticosterone levels and on the small intestinal injury. 
Because of higher basal plasma corticosterone levels in 
the evening hours in control vehicle treated rats (normal 
circadian rhythm of nocturnal animals) IM-induced 
elevation in plasma corticosterone levels was significant 
only during the morning hours. The intestinal lesions, 
as we demonstrated for the first time, were smaller in 
rats treated with IM in the evening hours. This confirms 
previous conclusion that the circadian time of applica-
tion of the ulcerogenic stimulus must be considered as 
an important experimental factor (Savran et al. 1997). 
However, previously the development of IM-induced 
gastric injury was studied at an earlier time point, which 
was not evaluated in our present experiment. Moreover, 
our results support also the gastroprotective role of glu-
cocorticoids as more severe intestinal lesion detected at 
the nadir of corticosterone level (Filaretova 2013).
According to the results, the long lasting effects of IM 
treatment obtained were preceded by early somatic and 
behavioral changes. Moreover, somatic changes were 
found even during 24 h preliminary fasting of rats in 
the telemetric study (Fig. 1). Fasting is a required com-
ponent of gastric ulcerogenic models (Kato et al. 2009; 
Rios et al. 2010; Zelena and Filaretova 2010). Beside GI 
Fig. 3. Behavior on the elevated plus maze. The main anxi-
ety measure, open arm time (A), as well as the locomotion-
independent measure (Open arm entries (% of total); (B) was 
not influenced significantly by IM treatment and refeeding 
24 h before. There was a significant reduction of locomotion 
measured by both the closed arm entries (C) and well as tel-
emetric recordings (G) in IM-treated rats. Both the heart rate 
(E) and core body temperature (F) was reduced in IM-treated 
animals. The EPM-induced temperature elevation was not 
apparent in IM-treated rats. n=14; IM1d: indomethacin treat-
ment (35 mg/kg sc in fasted rats) 24 h before *p<0.05 vs. vehicle 
treated; **p<0.01 main treatment effect; +p<0.05; ++p<0.01 
vs. -60 min (initial).
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components our previous results have already shown 
that a general reduction in blood glucose induced by 
IM injection (Filaretova et al. 2002) is a key element 
in the pathogenesis of the injury triggering an increase 
in gastric motility (Laine et al. 2008; Hermann et al. 
2014). The results of 24 h telemetric recordings show 
circadian variation of heart rate, core body temperature, 
and locomotion with higher levels during the dark phase 
and lower levels during the light phase in control rats. 
The data are in agreement with other studies includ-
ing our previous one (Filaretova et al. 2011) and with 
normal circadian rhythms of nocturnal animals that 
are more active during the dark phase of the day. We 
further demonstrated for the first time that fasting itself 
resulted in significant changes in telemetrically recorded 
parameters with the most prominent changes in heart 
rate. Fasting caused a significant reduction in heart rate 
during both the light and dark phases and a decrease in 
the body temperature only during the light phase. On 
the contrary, fasting induced significant increase in lo-
comotion during the first hours of the dark phase which 
may be explained by a search for food. Taken together, 
fasting-induced general somatic changes observed in 
the present study can make the rats more vulnerable to 
ulcerogenic stimuli. 
Further data obtained demonstrate in general how 
sensitive rats are during various steps of experimental 
conditions: significant and long lasting increase in heart 
rate, core body temperature, and locomotion in response 
to s.c. saline injection as well as refeeding were detected 
(Fig. 2). Nevertheless, IM injection induced significant 
changes in heart rate and core body temperature even 
when compared to saline injection. Our previous results 
showed a long-term disruption of circadian rhythmicity 
following IM treatment (Filaretova et al. 2011), which 
could be anticipated upon present data (assuming that 
all studied parameters remained low as shown in Fig. 3), 
however this time we were concentrated on the first 24h 
of ulcer formation and healing. The earliest and strong-
est effect of IM occurred on body temperature detect-
able already 2 h after the IM injection, intensified with 
time and remained strong even during the light phase, 
till the end of observation. We did not find any effect 
of IM injection on heart rate during the development 
of gastric erosion but it was well visible later, approxi-
mately 3 h after refeeding during the dark phase and 
partly also during the light phase. These early somatic 
changes could prolong the recovery, thereby contribut-
ing to the development of long term aversive effects of 
ulcerogen IM injection.
Despite our expectation that IM-induced ulcera-
tion will be accompanied by enhanced anxiety-like 
behavior on EPM, we were unable to detect a clear 
reduction of the main measured parameters (open 
arm time and open/total entries). On the other hand, 
the IM-induced significant reduction of locomotion is 
also detectable after various stressor exposures (Carli 
et al. 1989; Klenerova et al. 2011) and can be a sign 
of anxiety-prone personality (Geerse et al. 2006). The 
ethologically relevant parameter, high self grooming 
 
Fig. 4. Difference in morning or evening treated/sampled 
animals. Indomethacin treatment (35 mg/kg s.c. in fasted rats) 
induced a significant reduction in the body (A) and thymus (B) 
weight and an elevation in adrenal weight (C) during 3 days 
examination period without any day effect. Plasma corticos-
terone levels (D) were higher in the evening and indomethacin 
induced elevation during the morning hours only. Areas of 
gastric (E) as well as intestinal (F) lesion were significantly 
larger after indomethacin treatment, because we had no GI 
injury (0 mm2) in saline-treated rats (without IM). On the 
contrary, the length of the intestine (G) was significantly lower 
compared to vehicle treated animals. The intestinal lesions 
were smaller in evening treated/sampled animals without day 
effect on other parameters. n=5; ++ p<0.01 main time effect 
compared to day 0; # p<0.05 vs. morning treatment; *p<0.05, 
**p<0.01 vs. vehicle injection.
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is an additional sign of anxiety (Bagdy et al. 2001; Lee 
et al. 2014). Its slightly higher level after IM treatment 
further suggests a tendency for more anxious pheno-
type. At the same time, reduced locomotion could 
be a prominent symptom among so-called sickness 
behaviors (Matsuoka and Narumiya 2008). Because 
in our hands it is not accompanied by fever (on the 
contrary, with reduced temperature), it seems much 
more likely that IM-induced reduced locomotion 
is a sign of anxiety-like behavior rather than a pure 
reflection of a disease state. Beside the behavioral 
parameters IM treatment reduced also the autonomic 
responses (temperature elevation) due to stressor 
(EPM) exposure. According to our knowledge beside 
a previous report from our group on enhanced heart 
rate and locomotion during the EPM test (Haller et al. 
2004) there is no report in the literature on changes 
of autonomic parameters during anxiety tests. The 
reduced reactivity detectable in IM-treated rats sug-
gest a disturbed adaptation to environmental stimuli 
(Roth et al. 2012), indicating an enhanced vulnerability 
to new challenges. 
These results suggest that fasting itself may induce 
somatic changes, which can make the animals more 
vulnerable to ulcerogen stimuli. Development of IM-
induced gastrointestinal lesions goes parallel with 
disturbances of heart rate, core body temperature, and 
chronic stress-like somatic changes as well as anxiety-
like behavior. We should be more aware of the existence 
of the brain-gut axis and study changes in the whole 
body rather than focusing on a specific organ.
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